Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 12, 2017 – The FDA announced the approval of GlaxoSmithKline’s Nucala (mepolizumab) for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
Return to publications